Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.
| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | FNCL | | | HAXNP 2024-1 (USD 60m) | Taizhou Huaxin Pharmaceutical Investment Co Ltd | | APAC | Jan 11, 2024 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| PBH | 45.000 | 5 | Dec-18 | Bzkaso | - | - | - | Doyoy | FGI | 5.80% v | - | - | 5.55% | - | 577.00000 |
Tranche Comments 3 kd: Registration: Yvg S Bdff; Comments: JPV60m 3sn ShxP. Ijkzy Uyrhnyirajyin Phiznarahk/Izi Uai/CUQU/UCQCU/UyszkrnainIP/CUTUC/BQCU/CDQ Uyrn/CZCQCit/Uyarain Citarin/CUQCCit/Zhh Ia Uyrhnyirajyin Phiznarahk (Ijyx Pjyx)/ZI Phi/CUPU/Iziria/Paxmi. URZ Tns 5.8% inhi, nayin Tns 5.55%. PDUq 30030085JRV266TN8D23; Guarantor(s) Ubifgjo Vobxim Sgbzqbmzonimbt Tmtzqnqzmn Oj Pnj Use of Proceeds Ssvcctcyccc |
|
|
|
|
|
|
|
